- Editas Medicine ( NASDAQ: EDIT ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open.
- The consensus EPS Estimate is -$0.80 (+1.2% Y/Y) and the consensus Revenue Estimate is $4.29M (+1028.9% Y/Y).
- Over the last 1 year, EDIT has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 4 downward. Revenue estimates have seen 0 upward revisions and 2 downward.
For further details see:
Editas Medicine Q2 2022 Earnings Preview